Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 6, p. s664, 2025. DOI: 10.25251/h3w8px06. Disponível em: https://skin.dermsquared.com/skin/article/view/3886. Acesso em: 17 apr. 2026.